Literature DB >> 9455736

Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma.

T Tashiro-Itoh1, T Ichida, Y Matsuda, T Satoh, M Sugiyama, Y Tanaka, T Ishikawa, S Itoh, M Nomoto, H Asakura.   

Abstract

Metallothionein is the carrier protein of heavy metal ions, such as copper (Cu) and zinc (Zn). In this study, the relationships among immunohistochemical expression of metallothionein, concentrations of Cu and Zn, histological differentiation and proliferative activity of hepatocellular carcinoma were investigated in 51 cases. The concentrations of Cu and Zn in both tumor and non-tumor tissues were determined using electron probe microanalysis. Immunohistochemical expression of metallothionein in tumor tissues decreased with the degree of differentiation, whereas the number of hepatocytes positive for Ki-67 increased. Furthermore, the concentrations of Cu and Zn in tumor tissues decreased with the degree of histological differentiation in human hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9455736     DOI: 10.1111/j.1600-0676.1997.tb01036.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  7 in total

Review 1.  Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Expert Rev Anticancer Ther       Date:  2012-01       Impact factor: 4.512

Review 2.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

Review 3.  The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2014-01-21       Impact factor: 4.742

4.  ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer.

Authors:  Renty B Franklin; Bernard A Levy; Jing Zou; Nader Hanna; Mohamed Mokhtar Desouki; Omar Bagasra; Leslie A Johnson; Leslie C Costello
Journal:  J Gastrointest Cancer       Date:  2012-06

Review 5.  The important role of the apoptotic effects of zinc in the development of cancers.

Authors:  Renty B Franklin; Leslie C Costello
Journal:  J Cell Biochem       Date:  2009-04-01       Impact factor: 4.429

6.  Expression of Drug-Resistant Factor Genes in Hepatocellular Carcinoma Patients Undergoing Chemotherapy with Platinum Complex by Arterial Infusion.

Authors:  Tomoya Sakurada; Masaharu Yoshikawa; Masahiko Sunaga; Eriko Kobayashi; Nobunori Satoh; Osamu Yokosuka; Shiro Ueda
Journal:  Pharmaceutics       Date:  2010-09-09       Impact factor: 6.321

7.  Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice.

Authors:  Shafinaz Abd Gani; Suleiman Alhaji Muhammad; Aminu Umar Kura; Farahnaz Barahuie; Mohd Zobir Hussein; Sharida Fakurazi
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.